The clinical utility of using an abbreviated histamine challenge protocol for assessing nonspecific airway reactivity was examined. The study group consisted of 12 male and 12 female nonsmoking asthmatic volunteers, 20 to 52 years old. Twenty were never smokers. The remaining four subjects had quit smoking within the last 6 months. Sixteen were receiving longterm bronchodilator medication. The subjects underwent the standard histamine challenge test which involved five inhalations of nine graded histamine doses ranging from 0.3 to 10.0mg/ml. They then underwent an abbreviated and modified abbreviated protocol in which 0.16, 2.12, and 10.6mg/ml histamine was inhaled. Measurements of 1 second forced expiratory volume (FEV1) were made every 30 seconds in the abbreviated protocol and every 3 minutes (min) in the modified abbreviated protocol. The abbreviated and modified abbreviated protocols required significantly less time to administer than the standard protocol, 17.5 and 30.4 versus 43.8min, respectively. The provocative dose, defined as the histamine dose required to cause a 20% decrease in FEV1, and the slope of the dose response curves of the standard protocol and the abbreviated and modified abbreviated protocols were statistically identical. The authors conclude that an abbreviated airway challenge with histamine can produce similar estimates of airway reactivity when compared with the standard method. This means that an abbreviated protocol based on histamine can be used to investigate nonspecific airway reactivity.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.